Windhover.com | Medtech Insight | The RPM Report | Inteleos | EBI
Subscriber Username:   Password: Forgot Password?
Health Care Business Intelligence, Analysis, Insight - Windhover
Search


Receive Windhover's unique market insight fast with our free alert service 'Windhover's Update', including the latest abstracts and summaries from:

• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight


Sign up now

Corporate Offices
Connecticut Office
10 Hoyt Street
Norwalk, CT 06851
Tel: (203) 838-4401
Fax: (203) 838-3214
New Jersey Office
685 Route 202/206
Bridgewater NJ 08807
Toll Free: (800) 332-2181
Tel: (908) 547-2159
Fax: (908) 547-2165
Email Us
Maryland Office
5635 Fishers Lane
Rockville MD 20852
Tel: (800) 332-2181
Fax: (240) 221-4400
Email Us - Website
California Office
1 Technology Drive
Building J, Suite 703
Irvine CA 92618
Tel: (949) 453-0071
Fax: (949) 453-0072
Email Us - Website
Departments
Customer Care 
Toll Free: (800) 332-2181
Tel: (908) 547-2159
Fax: (908) 547-2165
Email Us
Conferences
Tel: (203) 838-4401 ext. 113, 119
Fax: (203) 838-3214
Email Us
Reprints
Tel: (203) 838-4401 ext. 124
Fax: (203) 838-3214
Email Us
Editorial
Tel: (203) 838-4401
Fax: (203) 838-3214
Email Us
Advertising & Sponsorships
Ken May
Director, Commercial Sales

Tel: (914) 332-1419
Mobile: (914) 356-5107
Email Us
Strategic Transactions & Inteleos
Sales & Client Support
Tel: (203) 838-4401 ext. 104
Email Us
Technical Support / IT
Tel: (203) 838-4401 ext. 236
Fax: (203) 838-3214
Email Us
 

The IN VIVO Blog

BIOWindhover/Pharmaceutical Strategic Outlook
February 23-25, 2010 · New York, NY

IN3 West + Investor Day
March 3-5, 2010 · Las Vegas, NV

IN3 Europe + Investor Day
April 28-30, 2010 · Paris, France

Interested in presenting at a Windhover conference?
Submit your idea here


Biopharma Trends: Nowhere To Go But Up
Biopharmaceutical trends in 2008 were fundamentally altered by the global financial crisis. And 2009's events were similarly impacted by the ongoing recovery. . . [MORE] (IN VIVO)

The A-List: 2009's Trend-Shaping Series A Financings
New company creation slipped significantly in 2009 as venture capitalists conserved capital and supported existing portfolio companies. . . [MORE] (Start-Up)

Stent Market Doldrums Push Interest Elsewhere
The new realities of the drug-eluting stent market are evident in recent sales results from the big competitors, driving many of them to branch into other higher growth areas. . . [MORE] (Medtech Insight)

The Future of Pharma: The Scale to Fail
The pharmaceutical sector saw a wave of major consolidation in 2009. There are a number of lessons to be learned from the M&A activity that can be applied to the New Year, including the increasing need to get bigger in order to absorb the R&D misses. . . [MORE] (The RPM Report)

Read more from the latest: IN VIVO, Start-Up, The RPM Report, Medtech Insight, "The Pink Sheet", "The Pink Sheet" DAILY, "The Rose Sheet", "The Tan Sheet", PharmAsia News, Pharmaceutical Approvals Monthly, and "The Gray Sheet".




Pharma Deals
  FDA Has Full Plate This Fall for Vaccines: More Than H1N1
  GSK Slides Away From Innovation
  The Billion Dollar REMS: Xenazine?
Device Deals
  Stroke Devices: Facing Challenges Head On
  Vascular Closure Devices at the Crossroads
  What New Her2 Tests Say about Personalized Medicine

Interested in subscribing? Click here.
Publications - Databases - Conferences - About Us - Contact Us - Help - The IN VIVO Blog - Company Profiles - Subscriber Login

Copyright © 2010, Windhover Information, Inc. An Elsevier company. All rights reserved.

Elsevier Business Intelligence